Cargando…

Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer

BACKGROUND: A major problem in cancer chemotherapy is the existence of primary resistance and/or the acquisition of secondary resistance. Many cellular defects contribute to chemoresistance, but epigenetic changes can also be a cause. METHODS: A DNA methylation microarray was used to identify epigen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moutinho, Catia, Martinez-Cardús, Anna, Santos, Cristina, Navarro-Pérez, Valentin, Martínez-Balibrea, Eva, Musulen, Eva, Carmona, F. Javier, Sartore-Bianchi, Andrea, Cassingena, Andrea, Siena, Salvatore, Elez, Elena, Tabernero, Josep, Salazar, Ramon, Abad, Albert, Esteller, Manel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906989/ https://www.ncbi.nlm.nih.gov/pubmed/24273214 http://dx.doi.org/10.1093/jnci/djt322

Ejemplares similares

PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines
por: Ginés, Alba, et al.
Publicado: (2015)

Mice Immunized with IgG Anti-Sheep Red Blood Cells (SRBC) Together With SRBC Have a Suppressed Anti-SRBC Antibody Response but Generate Germinal Centers and Anti-IgG Antibodies in Response to the Passively Administered IgG
por: Bergström, Joakim J. E., et al.
Publicado: (2017)

Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2016)

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs
por: Nogales, Vanesa, et al.
Publicado: (2015)

B cell intrinsic and extrinsic factors impacting memory recall responses to SRBC challenge
por: Valeri, Viviana, et al.
Publicado: (2022)

Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2019)

CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer
por: Ferreira, Humberto J., et al.
Publicado: (2012)

Refinement of computational identification of somatic copy number alterations using DNA methylation microarrays illustrated in cancers of unknown primary
por: Blecua, Pedro, et al.
Publicado: (2022)

TAK1 deficiency in dendritic cells inhibits adaptive immunity in SRBC‐immunized C57BL/6 mice
por: Pan, Yao, et al.
Publicado: (2016)

Ultra-efficient catalytic degradation of malachite green dye wastewater by KMnO(4)-modified biochar (Mn/SRBC)
por: Zhu, Hao, et al.
Publicado: (2022)

Oxaliplatin prior to PARP inhibitor in BRCA-mutated ovarian cancer
por: Nicoletto, Maria Ornella, et al.
Publicado: (2023)

Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome
por: Garcia-Prieto, Carlos A., et al.
Publicado: (2022)

A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
por: Lopez-Serra, Paula, et al.
Publicado: (2014)

Corrigendum: A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
por: Lopez-Serra, Paula, et al.
Publicado: (2016)

Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study
por: Amatu, Alessio, et al.
Publicado: (2022)

The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals
por: Carrato, Cristina, et al.
Publicado: (2021)

Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
por: Gonçalves-Ribeiro, Samuel, et al.
Publicado: (2016)

BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control
por: Stefansson, Olafur Andri, et al.
Publicado: (2012)

Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data
por: Bernat-Peguera, Adrià, et al.
Publicado: (2022)

Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer
por: Romeo, Margarita, et al.
Publicado: (2018)

Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases
por: Giannini, Valentina, et al.
Publicado: (2022)

Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in KRAS-Mutant Metastatic Colorectal Cancer
por: Siena, Salvatore, et al.
Publicado: (2013)

BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity
por: Katheeja, Muhseena N., et al.
Publicado: (2023)

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
por: Amatu, Alessio, et al.
Publicado: (2016)

Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients
por: Crisafulli, Giovanni, et al.
Publicado: (2019)

Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment
por: Amatu, Alessio, et al.
Publicado: (2022)

Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived Organoids
por: Mauri, Gianluca, et al.
Publicado: (2021)

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
por: Ferreira, H J, et al.
Publicado: (2016)

Erratum: DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
por: Ferreira, H J, et al.
Publicado: (2017)

Validation of DNA methylation profiling in formalin-fixed paraffin-embedded samples using the Infinium HumanMethylation450 Microarray
por: Moran, Sebastián, et al.
Publicado: (2014)

BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
por: Stefansson, Olafur A., et al.
Publicado: (2012)

Editorial: Transcriptional Regulation as a Key Player in Cancer Cells Drug Resistance
por: Martinez-Balibrea, Eva, et al.
Publicado: (2021)

Hypoxia: The Cornerstone of Glioblastoma
por: Domènech, Marta, et al.
Publicado: (2021)

Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer
por: Pérez-Salvia, Montserrat, et al.
Publicado: (2017)

Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report
por: Mauri, Gianluca, et al.
Publicado: (2023)

Regulation of cytohesins by their interactors in the nervous system
por: Zhai, Yuqi, et al.
Publicado: (2023)

Identification of Trombospondin-1 as a Novel Amelogenin Interactor by Functional Proteomics
por: Capolupo, Angela, et al.
Publicado: (2017)

Proteomic Analysis and Identification of Cellular Interactors of the Giant Ubiquitin Ligase HERC2
por: Galligan, Jeffrey T., et al.
Publicado: (2014)

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
por: Martinez-Balibrea, E, et al.
Publicado: (2010)

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
por: Siena, Salvatore, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fgmqm95mcpj2tkivrsf9jqhfgq